1,990
Views
21
CrossRef citations to date
0
Altmetric
Research Paper

Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003–2015

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 2554-2560 | Received 02 Jan 2019, Accepted 01 Apr 2019, Published online: 07 May 2019

References

  • Widgren K, Giesecke J, Lindquist L, Tegnell A. The burden of chickenpox disease in Sweden. BMC Infect Dis. 2016;16(1):666. doi:10.1186/s12879-016-1957-5.
  • Marinelli I, van Lier A, de Melker H, Pugliese A, van Boven M. Estimation of age-specific rates of reactivation and immune boosting of the varicella zoster virus. Epidemics. 2017;19:1–12. doi:10.1016/j.epidem.2016.11.001.
  • Hope-Simpson RE. The nature of herpes zoster: A long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9–20.
  • Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global varicella vaccine effectiveness: A meta-analysis. Pediatrics. 2016;137(3):e20153741. doi:10.1542/peds.2015-3741.
  • Wutzler P, Bonanni P, Burgess M, Gershon A, Safadi MA, Casabona G. Varicella vaccination - the global experience. Expert Rev Vaccines. 2017;16(8):833–43. doi:10.1080/14760584.2017.1343669.
  • Seward JF, Marin M, Vazquez M. Varicella vaccine effectiveness in the US vaccination program: a review. J Infect Dis. 2008;197(2):S82–9. doi:10.1086/522145.
  • Bechini A, Boccalini S, Baldo V, Cocchio S, Castiglia P, Gallo T, Giuffrida S, Locuratolo F, Tafuri S, Martinelli D, et al. Impact of universal vaccination against varicella in Italy. Hum Vaccin Immunother. 2015;11(1):63–71. doi:10.4161/hv.34311.
  • Latasa P, Gil de Miguel A, Barranco Ordonez MD, Rodero Garduno I, Sanz Moreno JC, Ordobas Gavin M, Esteban Vasallo M, Garrido-Estepa M, Garcia-Comas L. Effectiveness and impact of a single-dose vaccine against chickenpox in the community of Madrid between 2001 and 2015. Hum Vaccin Immunother. 2018;14(9):2274–80. doi:10.1080/21645515.2018.1475813.
  • Chang LY, Huang LM, Chang IS, Tsai FY. Epidemiological characteristics of varicella from 2000 to 2008 and the impact of nationwide immunization in Taiwan. BMC Infect Dis. 2011;11:352. doi:10.1186/1471-2334-11-352.
  • Wormsbecker AE, Wang J, Rosella LC, Kwong JC, Seo CY, Crowcroft NS, Deeks SL. Twenty years of medically-attended pediatric varicella and herpes zoster in Ontario, Canada: A population-based study. PLoS One. 2015;10(7):e0129483. doi:10.1371/journal.pone.0129483.
  • Heywood AE, Wang H, Macartney KK, McIntyre P. Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study. Bull World Health Organ. 2014;92(8):593–604. doi:10.2471/BLT.13.132142.
  • Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Hum Vaccin Immunother. 2014;10(12):3594–600. doi:10.4161/hv.34426.
  • Chaves SS, Gargiullo P, Zhang JX, Civen R, Guris D, Mascola L, Seward JF. Loss of vaccine-induced immunity to varicella over time. N Engl J Med. 2007;356(11):1121–29. doi:10.1056/NEJMoa064040.
  • Ogunjimi B, Van Damme P, Beutels P. Herpes zoster risk reduction through exposure to chickenpox patients: A systematic multidisciplinary review. PLoS One. 2013;8(6):e66485. doi:10.1371/journal.pone.0066485.
  • Sadzot-Delvaux C, Rentier B, Wutzler P, Asano Y, Suga S, Yoshikawa T, Plotkin SA. Varicella vaccination in Japan, South Korea, and Europe. J Infect Dis. 2008;197(2):S185–90. doi:10.1086/522163.
  • Infectious diseases surveillance yearbook, 2015. Osong (Republic of Korea): Korea Centers for Disease Control and Prevention; 2016. [accessed 1 Oct 2018]. http://www.cdc.go.kr/npt/biz/npp/portal/nppPblctDtaView.do.
  • Lee SG. Korean national immunization survey, 2011. Osong (Republic of Korea): Korea Centers for Disease Control and Prevention; 2011. [accessed 1 Oct 2018]. https://www.kdevelopedia.org.
  • Lee SG Korean national immunization survey, 2013. Osong (Republic of Korea): Korea Centers for Disease Control and Prevention; 2013. [accessed 1 Oct 2018]. http://www.cdc.go.kr/CDC/cms/cmsFileDownload.jsp?fid=31&cid=26689&fieldName=attach1&index=1.
  • National childhood vaccination coverage among children aged 3 years in Korea, 2015. Osong (Republic of Korea): Korea Centers for Disease Prevention and Control; 2016. [accessed 1 Oct 2018]. http://www.cdc.go.kr/CDC/info/CdcKrinfo0726.jsp?menuIds=HOME001-MNU1132-MNU2430-MNU2689&fid=9955&q_type=&q_value=&cid=127096&pageNum=.
  • Lee YH, Choe YJ, Cho SI, Kang CR, Bang JH, M- D O, J- K L. Effectiveness of varicella vaccination program in preventing laboratory-confirmed cases in children in Seoul, Korea. J Korean Med Sci. 2016;31(12):1897–901. doi:10.3346/jkms.2016.31.12.1897.
  • Oh SH, Choi EH, Shin SH, Kim YK, Chang JK, Choi KM, Hur JK, Kim KH, Kim JY, Chung EH, et al. Varicella and varicella vaccination in South Korea. Clin Vaccine Immunol. 2014;21(5):762–68. doi:10.1128/CVI.00645-13.
  • Chun BC. Laws on infectious disease control in Korea: past, present and prospective. Infect Chemother. 2011;43(6):474–84. doi:10.3947/ic.2011.43.6.474.
  • Choi WS, Noh JY, Huh JY, Jo YM, Lee J, Song JY, Kim WJ, Cheong HJ. Disease burden of herpes zoster in Korea. J Clin Virol. 2010;47(4):325–29. doi:10.1016/j.jcv.2010.01.003.
  • Schmid DS, Jumaan AO. Impact of varicella vaccine on varicella-zoster virus dynamics. Clin Microbiol Rev. 2010;23(1):202–17. doi:10.1128/CMR.00031-09.
  • Lee HR, Cha SH, Kim KH Survey on efficacy and safety of varicella vaccine as a regular vaccine in Korea. Osong (Republic of Korea): Korea Centers for Disease Control and Prevention; 2005. [accessed 1 Oct 2018]. http://www.cdc.go.kr/CDC/cms/content/mobile/44/1144_view.html.
  • Shin YC, Lee MS, Kown SS, Ki M, Na B, Nam H, Lee SW, Choi BJ, Kim SI, Park YM Development of vaccination coverage estimation methods and evaluation indicators of national immunization program in Korea. Osong (Republic of Korea): Korea Centers for Disease Control and Prevention; 2005. [accessed 1 Aug 2018]. https://nip.cdc.go.kr/irgd/reference.do?service=getResearchView&strNum=44&GUISEQNUM=14.
  • World Health Organization.Systematic review of available evidence on effectiveness and duration of protection of varicella vaccines. Geneva (Switzerland): World Health Organization; 2014. [accessed 1 Sep 2018]. https://www.who.int/immunization/sage/meetings/2014/april/4_Systematic_review_on_effectiveness_and_duration_of_protection_of_varicella_vaccines.pdf.
  • Kim SH, Lee HJ, Park SE, Oh SH, Lee SY, Choi EH. Seroprevalence rate after one dose of varicella vaccine in infants. J Infect. 2010;61(1):66–72. doi:10.1016/j.jinf.2010.04.001.
  • Michalik DE, Steinberg SP, Larussa PS, Edwards KM, Wright PF, Arvin AM, Gans HA, Gershon AA. Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J Infect Dis. 2008;197(7):944–49. doi:10.1086/529043.
  • Bonanni P, Gershon A, Gershon M, Kulcsar A, Papaevangelou V, Rentier B, Sadzot-Delvaux C, Usonis V, Vesikari T, Weil-Olivier C, et al. Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses. Pediatr Infect Dis J. 2013;32(7):e305–13. doi:10.1097/INF.0b013e31828b7def.
  • Choi UY, Huh DH, Kim JH, Kang JH. Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group. Hum Vaccin Immunother. 2016;12(10):2560–64. doi:10.1080/21645515.2016.1190056.
  • Population by census, 2005–2015. 27 August 2018. Korean statistical information service; [accessed 27 Aug 2018]. http://kosis.kr/statisticsList/statisticsListIndex.do?menuId=M_01_01&vwcd=MT_ZTITLE&parmTabId=M_01_01&statId=1962001&themaId=A#A1.2.
  • Pediatric sentinel surveillance weekly report. Osong (Republic of Korea): Korea Centers for Disease Control and Prevention; 2012. [accessed 1 Oct 2018]. http://www.cdc.go.kr/CDC/info/CdcKrInfo0301.jsp?menuIds=HOME006-MNU3003-MNU2950-MNU2951&cid=12780.
  • Korea Centers for Disease Control and Prevention. The status of varicella in Korea. Public Health Weekly Rep. 2012;5:590–92.
  • Korea Centers for Disease Control and Prevention. Results of pediatric infectious disease sentinel surveillance in Korea, 2011. Public Health Weekly Rep. 2012;5:362–65.
  • Korea Centers for Disease Control and Prevention. The status of varicella reported through pediatric sentinel surveillance. Public Health Weekly Rep. 2008;1:69–73.
  • Roh NK, Park YM, Kang H, Choi GS, Kim BJ, Lee YW, Lew BL, Sim WY. Awareness, knowledge, and vaccine acceptability of herpes zoster in Korea: A multicenter survey of 607 patients. Ann Dermatol. 2015;27(5):531–38. doi:10.5021/ad.2015.27.5.531.
  • Yang TU, Cheong HJ, Song JY, Noh JY, Kim WJ. Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea. Hum Vaccin Immunother. 2015;11(3):719–26. doi:10.1080/21645515.2015.1008885.
  • Population projections for Korea (2015–2065). Edited by Statistics Korea. 2016. Government Complex-Daejeon, Republic of Korea: Statistics Korea; [accessed 1 May, 2018]. http://kostat.go.kr/portal/eng/pressReleases/8/8/index.board.
  • Choi WS, Choi JH, Kwon KT, Seo K, Kim MA, Lee SO, Hong YJ, Lee JS, Song JY, Bang JH, et al. Revised adult immunization guideline recommended by the Korean Society of Infectious Diseases, 2014. Infect Chemother. 2015;47(1):68–79. doi:10.3947/ic.2015.47.1.68.
  • Bresnitz EA. Merck vaccines for older adults. Proceedings of WHO Meeting on Immunization in the Elderly; 2017; Geneva (Switzerland). WHO.
  • Yang TU, Cheong HJ, Choi WS, Song JY, Noh JY, Kim WJ. Physician attitudes toward the herpes zoster vaccination in South Korea. Infect Chemother. 2014;46(3):194–98. doi:10.3947/ic.2014.46.3.194.
  • Kim YS, Seo HM, Bang CH, Lee JH, Park YG, Kim YJ, Kim GM, Park CJ, Park HJ, Yu DS, et al. Validation of herpes zoster diagnosis code in the medical record: A retrospective, multicenter study. Ann Dermatol. 2018;30(2):253–55. doi:10.5021/ad.2018.30.2.253.
  • Klompas M, Kulldorff M, Vilk Y, Bialek SR, Harpaz R. Herpes zoster and postherpetic neuralgia surveillance using structured data. Mayo Clin Proc. 2011;86(12):1146–53. doi:10.4065/mcp.2011.0305.
  • Brisson M, Melkonyan G, Drolet M, De Serres G, Thibeault R, De Wals P. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster. Vaccine. 2010;28(19):3385–97. doi:10.1016/j.vaccine.2010.02.079.
  • Song SO, Jung CH, Song YD, Park CY, Kwon HS, Cha BS, Park JY, Lee KU, Ko KS, Lee BW. Background and data configuration process of a nationwide population-based study using the Korean National Health Insurance System. Diabetes Metab J. 2014;38(5):395–403. doi:10.4093/dmj.2014.38.5.395.
  • Oh JK 2002. A cost-benefit analysis of varicella vaccination in Korea [dissertation]. Seoul (Rep of Korea): Seoul National University
  • Park SK Nationwide vaccination coverage level: conceptual methodology and survey. Osong (Republic of Korea): Korea Centers for Disease Control and Prevention; 2009. [accessed 1 Oct 2018]. https://nip.cdc.go.kr/irgd/reference.do?service=getResearchView&strNum=97&GUISEQNUM=22.
  • Song YG. Herpes zoster. Korean J Med. 2001;60:266–68.
  • Choi WS, Kwon SS, Lee J, Choi SM, Lee JS, Eom JS, Sohn JW, Choeng HJ. Immunity and the burden of herpes zoster. J Med Virol. 2014;86(3):525–30. doi:10.1002/jmv.23830.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.